900174-61-0

Basic information

• Product Name: 4-BroMo-1-Chloro-2-ethoxy-benzene
• Synonyms: 4-BroMo-1-Chloro-2-ethoxy-benzene;4-Bromo-l-chloro-2-ethoxybenzene
• CAS NO: 900174-61-0
• Molecular Formula: C₈H₈BrClO
• Molecular Weight: 235.50552
• EINECS: -0
• Mol File: 900174-61-0.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4-BroMo-1-Chloro-2-ethoxy-benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BroMo-1-Chloro-2-ethoxy-benzene(900174-61-0)
• EPA Substance Registry System: 4-BroMo-1-Chloro-2-ethoxy-benzene(900174-61-0)

Safety Data

• Hazardous Substances Data: 900174-61-0(Hazardous Substances Data)

Usage

Description

4-Bromo-1-chloro-2-ethoxy-benzene, with the molecular formula C8H8BrClO, is a chemical compound derived from benzene. It is characterized by the presence of a bromine atom at the 4-position, a chlorine atom at the 1-position, and an ethoxy group at the 2-position. This versatile compound is primarily used as a building block in organic synthesis, offering a range of applications across different industries.

Uses

Used in Pharmaceutical Industry:
4-Bromo-1-chloro-2-ethoxy-benzene is used as a key intermediate in the synthesis of various drugs and pharmaceuticals. Its unique structural features and reactivity make it a valuable component in the development of new medications and therapeutic agents.
Used in Organic Chemistry Reactions:
4-BroMo-1-Chloro-2-ethoxy-benzene serves as a reagent in various organic chemistry reactions, such as nucleophilic aromatic substitution and Suzuki coupling reactions. Its participation in these reactions contributes to the formation of new chemical entities with potential applications in various fields.
Used in Agrochemical Development:
4-Bromo-1-chloro-2-ethoxy-benzene has potential applications in the development of agrochemicals. Its versatile reactivity and structural features make it a promising candidate for the synthesis of new agrochemicals, which can be used in agriculture to protect crops and enhance productivity.
Used in Materials Sciences:
4-BroMo-1-Chloro-2-ethoxy-benzene also finds applications in materials sciences due to its unique properties. It can be used in the synthesis of new materials with specific characteristics, such as improved thermal stability, mechanical strength, or electrical conductivity.
Safety Precautions:
It is crucial to handle and use 4-bromo-1-chloro-2-ethoxy-benzene with caution and in accordance with proper safety protocols. As a potentially hazardous compound, it requires careful management to prevent adverse effects on health and the environment.

Upstream product

• 183802-98-4 5-bromo-2-chlorophenol 
• 75-03-6 ethyl iodide 

Downstream Products

• 1427470-74-3 C₁₅H₁₃ClO₂ 
• 1310956-28-5 C₁₄H₂₀BClO₃ 
• 1611446-03-7 C₁₆H₁₅ClN₄O₃ 
• 900174-62-1 3-ethoxy-4-chlorophenylboronic acid 

Relevant articles and documents

5-[3-[PIPERAZIN-1-YL]-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS 4 AND 5 INHIBITORS FOR TREATING E.G. OSTEOARTHRITIS

The present invention discloses 5-[3-[piperazin-l-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives according to Formula (I), wherein R1, R2, R3a, R3b, R6a, R6b, the subscript n and Cy are as defined herein. The present invention relates to compounds inhibiting ADAMTS 4 and 5 for the prophylaxis or treatment of inflammatory diseases or diseases involving degradation of cartilage or disruption of cartilage homeostasis, such as e.g. osteoarthritis.

Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants

The present invention provides novel phenylglycinamide derivatives of Formula (I) or (IV): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables W, W1, Y, Z, R7, R8, R9, and R11 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.

1-ARYL-4-SUBSTITUTED PIPERAZINES DERIVATIVES FOR USE AS CCR1 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATION AND IMMUNE DISORDERS

Compounds are provided that act as potent antagonists of the CCR1 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR1. The compounds are generally aryl piperazine derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.